Abstract
Abstract
Background
Direct oral anticoagulants (DOAC) effectively prevent recurrent ischaemic events in atrial fibrillation (AF) patients with recent stroke. However, excellent adherence to DOAC is mandatory to guarantee sufficient anticoagulation as the effect quickly subsides.
Aim
To investigate the effect of intake reminders on adherence to DOAC.
Methods
MAAESTRO was a randomised, cross-over study in DOAC-treated AF patients hospitalised for ischaemic stroke. Adherence was measured by electronic monitoring for 12 months. After an observational phase, patients were randomised to obtain an intake reminder either in the first or the second half of the subsequent 6-month interventional phase. The primary outcome was 100%-timing adherence. Secondary outcomes were 100%-taking adherence, and overall timing and taking adherence. We analysed adherence outcomes using McNemar’s test or mixed-effects logistic models.
Results
Between January 2018 and March 2022, 130 stroke patients were included, of whom 42 dropped out before randomisation. Analysis was performed with 84 patients (mean age: 76.5 years, 39.3% women). A 100%-timing adherence was observed in 10 patients who were using the reminder, and in zero patients without reminder (p = 0.002). The reminder significantly improved adherence to DOAC, with study participants having 2.7-fold increased odds to achieve an alternative threshold of 90%-timing adherence (OR 2.65; 95% CI 1.05–6.69; p = 0.039). A similar effect was observed for 90%-taking adherence (OR 3.06; 95% CI 1.20–7.80; p = 0.019). Overall timing and taking adherence increased significantly when using the reminder (OR 1.70; 95% CI 1.55–1.86, p < 0.01; and OR 1.67; 95% CI 1.52–1.84; p < 0.01).
Conclusion
Intake reminders increased adherence to DOAC in patients with stroke attributable to atrial fibrillation.
Trial registration
ClinicalTrials.gov: NCT03344146.
Funder
University of Basel, Neurology and Scientific Fund of the University Hospital Basel
Swiss Academy of Medical Sciences and the Bangerter-Foundation
University of Basel
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference35 articles.
1. Raparelli V, Proietti M, Cangemi R et al (2017) Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thromb Haemost 117(2):209–218
2. Solla-Ruiz I, Villanueva-Benito I, Paredes-Galan E et al (2019) Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study. Thromb Res 179:20–27
3. Tiili P, Leventis I, Kinnunen J et al (2021) Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation. Ann Med 53(1):1613–1620
4. Hindricks G, Potpara T, Dagres N et al (2020) ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020:1–126
5. Chambers JA, O’Carroll RE, Hamilton B et al (2011) Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol 16(3):592–609
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献